Abstract:Long intergenic non-protein coding RNA, P53 induced transcript (LINC-PINT) exhibits different expression patterns in the majority of tumors, yet its relationship with cancer prognosis remains a subject of debate. This study aims to comprehensively investigate the prognostic significance of LINC-PINT in diverse human cancer. A systematic search was conducted in PubMed, Embase, Cochrane Library, and Web of Science databases to identify pertinent studies exploring the correlation between LINC-PINT expression and cancer patients. Moreover, bioinformatics analysis and in vitro validation were used to validate the results of the meta-analysis and to investigate the potential oncogenic mechanism of LINC-PINT. The meta-analysis encompassed 8 studies, involving 911 patients. The pooled analysis demonstrated a significant association between upregulation of LINC-PINT expression and better survival ( P = 0.002) during the cancers. Meanwhile, its downregulation was correlated with advanced tumor staging ( P = 0.04) and tumor differentiation ( P = 0.03). Additionally, bioinformatics analysis showed that LINC-PINT expression was observed to be linked with Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in tumors, the results of bioinformatics were verified by qRT-PCR. And functional enrichment analysis hinted at its involvement in tumorigenesis and tumor progression. Dysregulated LICN-PINT expression is associated with the clinical prognostic and pathological features of various cancers, exhibiting substantial potential as a novel prognostic biomarker.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the prognostic significance of long non - coding RNA LINC - PINT in different human cancers. Specifically, the study aims to comprehensively investigate the relationship between LINC - PINT expression and the survival rate of cancer patients, and explore its potential as a novel prognostic biomarker. LINC - PINT shows different expression patterns in various tumors, but its association with cancer prognosis remains controversial. Therefore, this study uses systematic review and meta - analysis methods, combined with bioinformatics analysis and in vitro validation experiments, to clarify the prognostic value of LINC - PINT in different cancer types and its underlying carcinogenic mechanisms.
### Main research contents:
1. **Literature search and screening**:
- The research team conducted a systematic search in the PubMed, Embase, Cochrane Library, and Web of Science databases to identify relevant studies.
- The screening criteria included using qRT - PCR or RNA - seq to evaluate the expression of LINC - PINT in tumor tissues, providing a description of the relationship between LINC - PINT expression and survival outcomes or clinicopathological parameters (CP), and reporting the hazard ratio (HR) and the corresponding 95% confidence interval (CI).
2. **Data extraction and quality assessment**:
- Key information was extracted from the selected studies, including authors, publication year, study area, sample size, cancer type, detection method, follow - up time, HR, and 95% CI.
- The Newcastle–Ottawa Scale (NOS) was used to assess the quality of the included studies.
3. **Meta - analysis**:
- A total of 8 studies involving 911 patients were pooled and analyzed.
- The results showed that up - regulated LINC - PINT expression was significantly associated with better overall survival (OS) (HR = 1.50, 95% CI (1.17, 1.93), P = 0.002).
- Further subgroup analysis indicated that this association remained consistent across different follow - up times, cancer systems, sample sizes, and treatment modalities.
4. **Relationship between LINC - PINT expression and clinicopathological parameters**:
- Low LINC - PINT expression was significantly associated with advanced tumor stage (OR = 6.28, 95% CI (1.10, 36.00), P = 0.04) and tumor differentiation grade (OR = 3.77, 95% CI (1.11, 12.82), P = 0.03).
- No significant association was found between LINC - PINT expression and age, gender, tumor size, and metastasis.
5. **Bioinformatics analysis**:
- Using data from the TCGA database, the expression differences and survival analysis of LINC - PINT in 33 different types of cancer were analyzed.
- It was found that in some specific types of cancer, such as bladder urothelial carcinoma, invasive breast carcinoma, and lung squamous cell carcinoma, the expression level of LINC - PINT decreased significantly as the tumor stage progressed.
- Functional enrichment analysis showed that genes related to LINC - PINT were mainly involved in processes such as RNA regulation, PPAR signaling pathway, and Th17 cell differentiation.
6. **In vitro validation experiments**:
- The expression of LINC - PINT in colorectal cancer and breast cancer cell lines was verified by qRT - PCR experiments, further supporting the results of bioinformatics analysis.
### Conclusion:
The expression level of LINC - PINT is closely related to the prognosis of multiple cancers, especially its up - regulation is associated with better survival rate. In addition, the change in LINC - PINT expression is also related to tumor stage and differentiation grade, indicating that LINC - PINT has the potential as a novel prognostic biomarker. However, the role of LINC - PINT in different cancer types may be different, and further research is needed to verify its specific function in specific cancers.